MedPage Today on MSN
Upadacitinib Delivers Durable 1-Year Benefits in Real-World UC
More than 60% of patients in large U.S. cohort achieved clinical remission at 1 year ...
A longer prednisolone tapering period is better than a shorter one at improving the rate of clinical remission in patients with moderate-to-severe ulcerative colitis.
Everyday Health on MSN
7 foods to swap during an ulcerative colitis flare
Learn how to adjust your diet to manage ulcerative colitis symptoms during a flare. Trade foods that exacerbate UC for those ...
Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...
MedPage Today on MSN
Upadacitinib Shows 1-Year Benefit in Pediatric IBD
Single-center study finds durable, steroid-free remission, especially in ulcerative coliti ...
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S.
Vedolizumab is associated with lower venous thromboembolism and cardiovascular event risk than TNF inhibitors in UC.
Our extensive research on the Medical Tapes and Bandages (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment opp ...
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results